Global Somatostatin Market Insights, Forecast to 2026
Somatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormones such as growth hormone, insulin, and gastrin.
Somatostatin is one of the fastest growing medical Products in recent years in China. China is also the world's most rapid expansion Market. Rapid growth numbers of general hospital form a strong Market Demand of Somatostatin, especially the demand of second class and below second class hospital.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Somatostatin 3900 market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Somatostatin 3900 industry.
Based on our recent survey, we have several different scenarios about the Somatostatin 3900 YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 269 million in 2019. The market size of Somatostatin 3900 will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Somatostatin market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Somatostatin market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Somatostatin market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Somatostatin market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Somatostatin market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Somatostatin market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Somatostatin market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Somatostatin market.
The following manufacturers are covered in this report:
Somatostatin is one of the fastest growing medical Products in recent years in China. China is also the world's most rapid expansion Market. Rapid growth numbers of general hospital form a strong Market Demand of Somatostatin, especially the demand of second class and below second class hospital.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Somatostatin 3900 market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Somatostatin 3900 industry.
Based on our recent survey, we have several different scenarios about the Somatostatin 3900 YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 269 million in 2019. The market size of Somatostatin 3900 will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Somatostatin market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Somatostatin market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Somatostatin market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Somatostatin market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Somatostatin market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Somatostatin market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Somatostatin market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Somatostatin market.
The following manufacturers are covered in this report:
- Merck (Schweiz) AG
- SANOFI-AVENTIS FRANCE
- Lyomark Pharma GmbH
- ALFA WASSERMANN S.p.A.
- Polypeptide Laboratories, Inc
- SAMARTH
- UBPL
- HYBIO
- TianTaiShan
- Yangtze River
- Siyao
- Shuangcheng
- Hainan Zhonghe
- SL PHARM
- Wuhan Hualong
- Qingdao Guoda
- Chengdu Shengnuo
- Longjin
- 0.25
- 0.75
- 3
- Hormonal Disorder
- Oncology
- Metabolic Disorder
- Others
1 STUDY COVERAGE
1.1 Somatostatin Product Introduction
1.2 Market Segments
1.3 Key Somatostatin Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Somatostatin Market Size Growth Rate by Type
1.4.2 0.25
1.4.3 0.75
1.4.4
1.5 Market by Application
1.5.1 Global Somatostatin Market Size Growth Rate by Application
1.5.2 Hormonal Disorder
1.5.3 Oncology
1.5.4 Metabolic Disorder
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Somatostatin Industry Impact
1.6.1 How the Covid-19 is Affecting the Somatostatin Industry
1.6.1.1 Somatostatin Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Somatostatin Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Somatostatin Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Somatostatin Market Size Estimates and Forecasts
2.1.1 Global Somatostatin Revenue 2015-2026
2.1.2 Global Somatostatin Sales 2015-2026
2.2 Somatostatin Market Size by Region: 2020 Versus 2026
2.2.1 Global Somatostatin Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Somatostatin Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL SOMATOSTATIN COMPETITOR LANDSCAPE BY PLAYERS
3.1 Somatostatin Sales by Manufacturers
3.1.1 Somatostatin Sales by Manufacturers (2015-2020)
3.1.2 Somatostatin Sales Market Share by Manufacturers (2015-2020)
3.2 Somatostatin Revenue by Manufacturers
3.2.1 Somatostatin Revenue by Manufacturers (2015-2020)
3.2.2 Somatostatin Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Somatostatin Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Somatostatin Revenue in 2019
3.2.5 Global Somatostatin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Somatostatin Price by Manufacturers
3.4 Somatostatin Manufacturing Base Distribution, Product Types
3.4.1 Somatostatin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Somatostatin Product Type
3.4.3 Date of International Manufacturers Enter into Somatostatin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Somatostatin Market Size by Type (2015-2020)
4.1.1 Global Somatostatin Sales by Type (2015-2020)
4.1.2 Global Somatostatin Revenue by Type (2015-2020)
4.1.3 Somatostatin Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Somatostatin Market Size Forecast by Type (2021-2026)
4.2.1 Global Somatostatin Sales Forecast by Type (2021-2026)
4.2.2 Global Somatostatin Revenue Forecast by Type (2021-2026)
4.2.3 Somatostatin Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Somatostatin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Somatostatin Market Size by Application (2015-2020)
5.1.1 Global Somatostatin Sales by Application (2015-2020)
5.1.2 Global Somatostatin Revenue by Application (2015-2020)
5.1.3 Somatostatin Price by Application (2015-2020)
5.2 Somatostatin Market Size Forecast by Application (2021-2026)
5.2.1 Global Somatostatin Sales Forecast by Application (2021-2026)
5.2.2 Global Somatostatin Revenue Forecast by Application (2021-2026)
5.2.3 Global Somatostatin Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Somatostatin by Country
6.1.1 North America Somatostatin Sales by Country
6.1.2 North America Somatostatin Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Somatostatin Market Facts & Figures by Type
6.3 North America Somatostatin Market Facts & Figures by Application
7 EUROPE
7.1 Europe Somatostatin by Country
7.1.1 Europe Somatostatin Sales by Country
7.1.2 Europe Somatostatin Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Somatostatin Market Facts & Figures by Type
7.3 Europe Somatostatin Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Somatostatin by Region
8.1.1 Asia Pacific Somatostatin Sales by Region
8.1.2 Asia Pacific Somatostatin Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Somatostatin Market Facts & Figures by Type
8.3 Asia Pacific Somatostatin Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Somatostatin by Country
9.1.1 Latin America Somatostatin Sales by Country
9.1.2 Latin America Somatostatin Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Somatostatin Market Facts & Figures by Type
9.3 Central & South America Somatostatin Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Somatostatin by Country
10.1.1 Middle East and Africa Somatostatin Sales by Country
10.1.2 Middle East and Africa Somatostatin Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Somatostatin Market Facts & Figures by Type
10.3 Middle East and Africa Somatostatin Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Merck (Schweiz) AG
11.1.1 Merck (Schweiz) AG Corporation Information
11.1.2 Merck (Schweiz) AG Description, Business Overview and Total Revenue
11.1.3 Merck (Schweiz) AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck (Schweiz) AG Somatostatin Products Offered
11.1.5 Merck (Schweiz) AG Recent Development
11.2 SANOFI-AVENTIS FRANCE
11.2.1 SANOFI-AVENTIS FRANCE Corporation Information
11.2.2 SANOFI-AVENTIS FRANCE Description, Business Overview and Total Revenue
11.2.3 SANOFI-AVENTIS FRANCE Sales, Revenue and Gross Margin (2015-2020)
11.2.4 SANOFI-AVENTIS FRANCE Somatostatin Products Offered
11.2.5 SANOFI-AVENTIS FRANCE Recent Development
11.3 Lyomark Pharma GmbH
11.3.1 Lyomark Pharma GmbH Corporation Information
11.3.2 Lyomark Pharma GmbH Description, Business Overview and Total Revenue
11.3.3 Lyomark Pharma GmbH Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Lyomark Pharma GmbH Somatostatin Products Offered
11.3.5 Lyomark Pharma GmbH Recent Development
11.4 ALFA WASSERMANN S.p.A.
11.4.1 ALFA WASSERMANN S.p.A. Corporation Information
11.4.2 ALFA WASSERMANN S.p.A. Description, Business Overview and Total Revenue
11.4.3 ALFA WASSERMANN S.p.A. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 ALFA WASSERMANN S.p.A. Somatostatin Products Offered
11.4.5 ALFA WASSERMANN S.p.A. Recent Development
11.5 Polypeptide Laboratories, Inc
11.5.1 Polypeptide Laboratories, Inc Corporation Information
11.5.2 Polypeptide Laboratories, Inc Description, Business Overview and Total Revenue
11.5.3 Polypeptide Laboratories, Inc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Polypeptide Laboratories, Inc Somatostatin Products Offered
11.5.5 Polypeptide Laboratories, Inc Recent Development
11.6 SAMARTH
11.6.1 SAMARTH Corporation Information
11.6.2 SAMARTH Description, Business Overview and Total Revenue
11.6.3 SAMARTH Sales, Revenue and Gross Margin (2015-2020)
11.6.4 SAMARTH Somatostatin Products Offered
11.6.5 SAMARTH Recent Development
11.7 UBPL
11.7.1 UBPL Corporation Information
11.7.2 UBPL Description, Business Overview and Total Revenue
11.7.3 UBPL Sales, Revenue and Gross Margin (2015-2020)
11.7.4 UBPL Somatostatin Products Offered
11.7.5 UBPL Recent Development
11.8 HYBIO
11.8.1 HYBIO Corporation Information
11.8.2 HYBIO Description, Business Overview and Total Revenue
11.8.3 HYBIO Sales, Revenue and Gross Margin (2015-2020)
11.8.4 HYBIO Somatostatin Products Offered
11.8.5 HYBIO Recent Development
11.9 TianTaiShan
11.9.1 TianTaiShan Corporation Information
11.9.2 TianTaiShan Description, Business Overview and Total Revenue
11.9.3 TianTaiShan Sales, Revenue and Gross Margin (2015-2020)
11.9.4 TianTaiShan Somatostatin Products Offered
11.9.5 TianTaiShan Recent Development
11.10 Yangtze River
11.10.1 Yangtze River Corporation Information
11.10.2 Yangtze River Description, Business Overview and Total Revenue
11.10.3 Yangtze River Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Yangtze River Somatostatin Products Offered
11.10.5 Yangtze River Recent Development
11.1 Merck (Schweiz) AG
11.1.1 Merck (Schweiz) AG Corporation Information
11.1.2 Merck (Schweiz) AG Description, Business Overview and Total Revenue
11.1.3 Merck (Schweiz) AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck (Schweiz) AG Somatostatin Products Offered
11.1.5 Merck (Schweiz) AG Recent Development
11.12 Shuangcheng
11.12.1 Shuangcheng Corporation Information
11.12.2 Shuangcheng Description, Business Overview and Total Revenue
11.12.3 Shuangcheng Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Shuangcheng Products Offered
11.12.5 Shuangcheng Recent Development
11.13 Hainan Zhonghe
11.13.1 Hainan Zhonghe Corporation Information
11.13.2 Hainan Zhonghe Description, Business Overview and Total Revenue
11.13.3 Hainan Zhonghe Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Hainan Zhonghe Products Offered
11.13.5 Hainan Zhonghe Recent Development
11.14 SL PHARM
11.14.1 SL PHARM Corporation Information
11.14.2 SL PHARM Description, Business Overview and Total Revenue
11.14.3 SL PHARM Sales, Revenue and Gross Margin (2015-2020)
11.14.4 SL PHARM Products Offered
11.14.5 SL PHARM Recent Development
11.15 Wuhan Hualong
11.15.1 Wuhan Hualong Corporation Information
11.15.2 Wuhan Hualong Description, Business Overview and Total Revenue
11.15.3 Wuhan Hualong Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Wuhan Hualong Products Offered
11.15.5 Wuhan Hualong Recent Development
11.16 Qingdao Guoda
11.16.1 Qingdao Guoda Corporation Information
11.16.2 Qingdao Guoda Description, Business Overview and Total Revenue
11.16.3 Qingdao Guoda Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Qingdao Guoda Products Offered
11.16.5 Qingdao Guoda Recent Development
11.17 Chengdu Shengnuo
11.17.1 Chengdu Shengnuo Corporation Information
11.17.2 Chengdu Shengnuo Description, Business Overview and Total Revenue
11.17.3 Chengdu Shengnuo Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Chengdu Shengnuo Products Offered
11.17.5 Chengdu Shengnuo Recent Development
11.18 Longjin
11.18.1 Longjin Corporation Information
11.18.2 Longjin Description, Business Overview and Total Revenue
11.18.3 Longjin Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Longjin Products Offered
11.18.5 Longjin Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Somatostatin Market Estimates and Projections by Region
12.1.1 Global Somatostatin Sales Forecast by Regions 2021-2026
12.1.2 Global Somatostatin Revenue Forecast by Regions 2021-2026
12.2 North America Somatostatin Market Size Forecast (2021-2026)
12.2.1 North America: Somatostatin Sales Forecast (2021-2026)
12.2.2 North America: Somatostatin Revenue Forecast (2021-2026)
12.2.3 North America: Somatostatin Market Size Forecast by Country (2021-2026)
12.3 Europe Somatostatin Market Size Forecast (2021-2026)
12.3.1 Europe: Somatostatin Sales Forecast (2021-2026)
12.3.2 Europe: Somatostatin Revenue Forecast (2021-2026)
12.3.3 Europe: Somatostatin Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Somatostatin Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Somatostatin Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Somatostatin Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Somatostatin Market Size Forecast by Region (2021-2026)
12.5 Latin America Somatostatin Market Size Forecast (2021-2026)
12.5.1 Latin America: Somatostatin Sales Forecast (2021-2026)
12.5.2 Latin America: Somatostatin Revenue Forecast (2021-2026)
12.5.3 Latin America: Somatostatin Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Somatostatin Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Somatostatin Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Somatostatin Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Somatostatin Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Somatostatin Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Somatostatin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Somatostatin Product Introduction
1.2 Market Segments
1.3 Key Somatostatin Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Somatostatin Market Size Growth Rate by Type
1.4.2 0.25
1.4.3 0.75
1.4.4
1.5 Market by Application
1.5.1 Global Somatostatin Market Size Growth Rate by Application
1.5.2 Hormonal Disorder
1.5.3 Oncology
1.5.4 Metabolic Disorder
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Somatostatin Industry Impact
1.6.1 How the Covid-19 is Affecting the Somatostatin Industry
1.6.1.1 Somatostatin Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Somatostatin Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Somatostatin Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Somatostatin Market Size Estimates and Forecasts
2.1.1 Global Somatostatin Revenue 2015-2026
2.1.2 Global Somatostatin Sales 2015-2026
2.2 Somatostatin Market Size by Region: 2020 Versus 2026
2.2.1 Global Somatostatin Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Somatostatin Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL SOMATOSTATIN COMPETITOR LANDSCAPE BY PLAYERS
3.1 Somatostatin Sales by Manufacturers
3.1.1 Somatostatin Sales by Manufacturers (2015-2020)
3.1.2 Somatostatin Sales Market Share by Manufacturers (2015-2020)
3.2 Somatostatin Revenue by Manufacturers
3.2.1 Somatostatin Revenue by Manufacturers (2015-2020)
3.2.2 Somatostatin Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Somatostatin Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Somatostatin Revenue in 2019
3.2.5 Global Somatostatin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Somatostatin Price by Manufacturers
3.4 Somatostatin Manufacturing Base Distribution, Product Types
3.4.1 Somatostatin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Somatostatin Product Type
3.4.3 Date of International Manufacturers Enter into Somatostatin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Somatostatin Market Size by Type (2015-2020)
4.1.1 Global Somatostatin Sales by Type (2015-2020)
4.1.2 Global Somatostatin Revenue by Type (2015-2020)
4.1.3 Somatostatin Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Somatostatin Market Size Forecast by Type (2021-2026)
4.2.1 Global Somatostatin Sales Forecast by Type (2021-2026)
4.2.2 Global Somatostatin Revenue Forecast by Type (2021-2026)
4.2.3 Somatostatin Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Somatostatin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Somatostatin Market Size by Application (2015-2020)
5.1.1 Global Somatostatin Sales by Application (2015-2020)
5.1.2 Global Somatostatin Revenue by Application (2015-2020)
5.1.3 Somatostatin Price by Application (2015-2020)
5.2 Somatostatin Market Size Forecast by Application (2021-2026)
5.2.1 Global Somatostatin Sales Forecast by Application (2021-2026)
5.2.2 Global Somatostatin Revenue Forecast by Application (2021-2026)
5.2.3 Global Somatostatin Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Somatostatin by Country
6.1.1 North America Somatostatin Sales by Country
6.1.2 North America Somatostatin Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Somatostatin Market Facts & Figures by Type
6.3 North America Somatostatin Market Facts & Figures by Application
7 EUROPE
7.1 Europe Somatostatin by Country
7.1.1 Europe Somatostatin Sales by Country
7.1.2 Europe Somatostatin Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Somatostatin Market Facts & Figures by Type
7.3 Europe Somatostatin Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Somatostatin by Region
8.1.1 Asia Pacific Somatostatin Sales by Region
8.1.2 Asia Pacific Somatostatin Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Somatostatin Market Facts & Figures by Type
8.3 Asia Pacific Somatostatin Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Somatostatin by Country
9.1.1 Latin America Somatostatin Sales by Country
9.1.2 Latin America Somatostatin Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Somatostatin Market Facts & Figures by Type
9.3 Central & South America Somatostatin Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Somatostatin by Country
10.1.1 Middle East and Africa Somatostatin Sales by Country
10.1.2 Middle East and Africa Somatostatin Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Somatostatin Market Facts & Figures by Type
10.3 Middle East and Africa Somatostatin Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Merck (Schweiz) AG
11.1.1 Merck (Schweiz) AG Corporation Information
11.1.2 Merck (Schweiz) AG Description, Business Overview and Total Revenue
11.1.3 Merck (Schweiz) AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck (Schweiz) AG Somatostatin Products Offered
11.1.5 Merck (Schweiz) AG Recent Development
11.2 SANOFI-AVENTIS FRANCE
11.2.1 SANOFI-AVENTIS FRANCE Corporation Information
11.2.2 SANOFI-AVENTIS FRANCE Description, Business Overview and Total Revenue
11.2.3 SANOFI-AVENTIS FRANCE Sales, Revenue and Gross Margin (2015-2020)
11.2.4 SANOFI-AVENTIS FRANCE Somatostatin Products Offered
11.2.5 SANOFI-AVENTIS FRANCE Recent Development
11.3 Lyomark Pharma GmbH
11.3.1 Lyomark Pharma GmbH Corporation Information
11.3.2 Lyomark Pharma GmbH Description, Business Overview and Total Revenue
11.3.3 Lyomark Pharma GmbH Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Lyomark Pharma GmbH Somatostatin Products Offered
11.3.5 Lyomark Pharma GmbH Recent Development
11.4 ALFA WASSERMANN S.p.A.
11.4.1 ALFA WASSERMANN S.p.A. Corporation Information
11.4.2 ALFA WASSERMANN S.p.A. Description, Business Overview and Total Revenue
11.4.3 ALFA WASSERMANN S.p.A. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 ALFA WASSERMANN S.p.A. Somatostatin Products Offered
11.4.5 ALFA WASSERMANN S.p.A. Recent Development
11.5 Polypeptide Laboratories, Inc
11.5.1 Polypeptide Laboratories, Inc Corporation Information
11.5.2 Polypeptide Laboratories, Inc Description, Business Overview and Total Revenue
11.5.3 Polypeptide Laboratories, Inc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Polypeptide Laboratories, Inc Somatostatin Products Offered
11.5.5 Polypeptide Laboratories, Inc Recent Development
11.6 SAMARTH
11.6.1 SAMARTH Corporation Information
11.6.2 SAMARTH Description, Business Overview and Total Revenue
11.6.3 SAMARTH Sales, Revenue and Gross Margin (2015-2020)
11.6.4 SAMARTH Somatostatin Products Offered
11.6.5 SAMARTH Recent Development
11.7 UBPL
11.7.1 UBPL Corporation Information
11.7.2 UBPL Description, Business Overview and Total Revenue
11.7.3 UBPL Sales, Revenue and Gross Margin (2015-2020)
11.7.4 UBPL Somatostatin Products Offered
11.7.5 UBPL Recent Development
11.8 HYBIO
11.8.1 HYBIO Corporation Information
11.8.2 HYBIO Description, Business Overview and Total Revenue
11.8.3 HYBIO Sales, Revenue and Gross Margin (2015-2020)
11.8.4 HYBIO Somatostatin Products Offered
11.8.5 HYBIO Recent Development
11.9 TianTaiShan
11.9.1 TianTaiShan Corporation Information
11.9.2 TianTaiShan Description, Business Overview and Total Revenue
11.9.3 TianTaiShan Sales, Revenue and Gross Margin (2015-2020)
11.9.4 TianTaiShan Somatostatin Products Offered
11.9.5 TianTaiShan Recent Development
11.10 Yangtze River
11.10.1 Yangtze River Corporation Information
11.10.2 Yangtze River Description, Business Overview and Total Revenue
11.10.3 Yangtze River Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Yangtze River Somatostatin Products Offered
11.10.5 Yangtze River Recent Development
11.1 Merck (Schweiz) AG
11.1.1 Merck (Schweiz) AG Corporation Information
11.1.2 Merck (Schweiz) AG Description, Business Overview and Total Revenue
11.1.3 Merck (Schweiz) AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck (Schweiz) AG Somatostatin Products Offered
11.1.5 Merck (Schweiz) AG Recent Development
11.12 Shuangcheng
11.12.1 Shuangcheng Corporation Information
11.12.2 Shuangcheng Description, Business Overview and Total Revenue
11.12.3 Shuangcheng Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Shuangcheng Products Offered
11.12.5 Shuangcheng Recent Development
11.13 Hainan Zhonghe
11.13.1 Hainan Zhonghe Corporation Information
11.13.2 Hainan Zhonghe Description, Business Overview and Total Revenue
11.13.3 Hainan Zhonghe Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Hainan Zhonghe Products Offered
11.13.5 Hainan Zhonghe Recent Development
11.14 SL PHARM
11.14.1 SL PHARM Corporation Information
11.14.2 SL PHARM Description, Business Overview and Total Revenue
11.14.3 SL PHARM Sales, Revenue and Gross Margin (2015-2020)
11.14.4 SL PHARM Products Offered
11.14.5 SL PHARM Recent Development
11.15 Wuhan Hualong
11.15.1 Wuhan Hualong Corporation Information
11.15.2 Wuhan Hualong Description, Business Overview and Total Revenue
11.15.3 Wuhan Hualong Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Wuhan Hualong Products Offered
11.15.5 Wuhan Hualong Recent Development
11.16 Qingdao Guoda
11.16.1 Qingdao Guoda Corporation Information
11.16.2 Qingdao Guoda Description, Business Overview and Total Revenue
11.16.3 Qingdao Guoda Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Qingdao Guoda Products Offered
11.16.5 Qingdao Guoda Recent Development
11.17 Chengdu Shengnuo
11.17.1 Chengdu Shengnuo Corporation Information
11.17.2 Chengdu Shengnuo Description, Business Overview and Total Revenue
11.17.3 Chengdu Shengnuo Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Chengdu Shengnuo Products Offered
11.17.5 Chengdu Shengnuo Recent Development
11.18 Longjin
11.18.1 Longjin Corporation Information
11.18.2 Longjin Description, Business Overview and Total Revenue
11.18.3 Longjin Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Longjin Products Offered
11.18.5 Longjin Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Somatostatin Market Estimates and Projections by Region
12.1.1 Global Somatostatin Sales Forecast by Regions 2021-2026
12.1.2 Global Somatostatin Revenue Forecast by Regions 2021-2026
12.2 North America Somatostatin Market Size Forecast (2021-2026)
12.2.1 North America: Somatostatin Sales Forecast (2021-2026)
12.2.2 North America: Somatostatin Revenue Forecast (2021-2026)
12.2.3 North America: Somatostatin Market Size Forecast by Country (2021-2026)
12.3 Europe Somatostatin Market Size Forecast (2021-2026)
12.3.1 Europe: Somatostatin Sales Forecast (2021-2026)
12.3.2 Europe: Somatostatin Revenue Forecast (2021-2026)
12.3.3 Europe: Somatostatin Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Somatostatin Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Somatostatin Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Somatostatin Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Somatostatin Market Size Forecast by Region (2021-2026)
12.5 Latin America Somatostatin Market Size Forecast (2021-2026)
12.5.1 Latin America: Somatostatin Sales Forecast (2021-2026)
12.5.2 Latin America: Somatostatin Revenue Forecast (2021-2026)
12.5.3 Latin America: Somatostatin Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Somatostatin Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Somatostatin Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Somatostatin Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Somatostatin Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Somatostatin Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Somatostatin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Somatostatin Market Segments
Table 2. Ranking of Global Top Somatostatin Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Somatostatin Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of 0.25
Table 5. Major Manufacturers of 0.75
Table 6. Major Manufacturers of 3
Table 7. COVID-19 Impact Global Market: (Four Somatostatin Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Somatostatin Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Somatostatin Players to Combat Covid-19 Impact
Table 12. Global Somatostatin Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 13. Global Somatostatin Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 14. Global Somatostatin Sales by Regions 2015-2020 (K Pcs)
Table 15. Global Somatostatin Sales Market Share by Regions (2015-2020)
Table 16. Global Somatostatin Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Somatostatin Sales by Manufacturers (2015-2020) (K Pcs)
Table 18. Global Somatostatin Sales Share by Manufacturers (2015-2020)
Table 19. Global Somatostatin Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Somatostatin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Somatostatin as of 2019)
Table 21. Somatostatin Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Somatostatin Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Somatostatin Price (2015-2020) (USD/Pcs)
Table 24. Somatostatin Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Somatostatin Product Type
Table 26. Date of International Manufacturers Enter into Somatostatin Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Somatostatin Sales by Type (2015-2020) (K Pcs)
Table 29. Global Somatostatin Sales Share by Type (2015-2020)
Table 30. Global Somatostatin Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Somatostatin Revenue Share by Type (2015-2020)
Table 32. Somatostatin Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 33. Global Somatostatin Sales by Application (2015-2020) (K Pcs)
Table 34. Global Somatostatin Sales Share by Application (2015-2020)
Table 35. North America Somatostatin Sales by Country (2015-2020) (K Pcs)
Table 36. North America Somatostatin Sales Market Share by Country (2015-2020)
Table 37. North America Somatostatin Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Somatostatin Revenue Market Share by Country (2015-2020)
Table 39. North America Somatostatin Sales by Type (2015-2020) (K Pcs)
Table 40. North America Somatostatin Sales Market Share by Type (2015-2020)
Table 41. North America Somatostatin Sales by Application (2015-2020) (K Pcs)
Table 42. North America Somatostatin Sales Market Share by Application (2015-2020)
Table 43. Europe Somatostatin Sales by Country (2015-2020) (K Pcs)
Table 44. Europe Somatostatin Sales Market Share by Country (2015-2020)
Table 45. Europe Somatostatin Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Somatostatin Revenue Market Share by Country (2015-2020)
Table 47. Europe Somatostatin Sales by Type (2015-2020) (K Pcs)
Table 48. Europe Somatostatin Sales Market Share by Type (2015-2020)
Table 49. Europe Somatostatin Sales by Application (2015-2020) (K Pcs)
Table 50. Europe Somatostatin Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Somatostatin Sales by Region (2015-2020) (K Pcs)
Table 52. Asia Pacific Somatostatin Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Somatostatin Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Somatostatin Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Somatostatin Sales by Type (2015-2020) (K Pcs)
Table 56. Asia Pacific Somatostatin Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Somatostatin Sales by Application (2015-2020) (K Pcs)
Table 58. Asia Pacific Somatostatin Sales Market Share by Application (2015-2020)
Table 59. Latin America Somatostatin Sales by Country (2015-2020) (K Pcs)
Table 60. Latin America Somatostatin Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Somatostatin Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Somatostatin Revenue Market Share by Country (2015-2020)
Table 63. Latin America Somatostatin Sales by Type (2015-2020) (K Pcs)
Table 64. Latin America Somatostatin Sales Market Share by Type (2015-2020)
Table 65. Latin America Somatostatin Sales by Application (2015-2020) (K Pcs)
Table 66. Latin America Somatostatin Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Somatostatin Sales by Country (2015-2020) (K Pcs)
Table 68. Middle East and Africa Somatostatin Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Somatostatin Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Somatostatin Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Somatostatin Sales by Type (2015-2020) (K Pcs)
Table 72. Middle East and Africa Somatostatin Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Somatostatin Sales by Application (2015-2020) (K Pcs)
Table 74. Middle East and Africa Somatostatin Sales Market Share by Application (2015-2020)
Table 75. Merck (Schweiz) AG Corporation Information
Table 76. Merck (Schweiz) AG Description and Major Businesses
Table 77. Merck (Schweiz) AG Somatostatin Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Merck (Schweiz) AG Product
Table 79. Merck (Schweiz) AG Recent Development
Table 80. SANOFI-AVENTIS FRANCE Corporation Information
Table 81. SANOFI-AVENTIS FRANCE Description and Major Businesses
Table 82. SANOFI-AVENTIS FRANCE Somatostatin Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. SANOFI-AVENTIS FRANCE Product
Table 84. SANOFI-AVENTIS FRANCE Recent Development
Table 85. Lyomark Pharma GmbH Corporation Information
Table 86. Lyomark Pharma GmbH Description and Major Businesses
Table 87. Lyomark Pharma GmbH Somatostatin Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Lyomark Pharma GmbH Product
Table 89. Lyomark Pharma GmbH Recent Development
Table 90. ALFA WASSERMANN S.p.A. Corporation Information
Table 91. ALFA WASSERMANN S.p.A. Description and Major Businesses
Table 92. ALFA WASSERMANN S.p.A. Somatostatin Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. ALFA WASSERMANN S.p.A. Product
Table 94. ALFA WASSERMANN S.p.A. Recent Development
Table 95. Polypeptide Laboratories, Inc Corporation Information
Table 96. Polypeptide Laboratories, Inc Description and Major Businesses
Table 97. Polypeptide Laboratories, Inc Somatostatin Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Polypeptide Laboratories, Inc Product
Table 99. Polypeptide Laboratories, Inc Recent Development
Table 100. SAMARTH Corporation Information
Table 101. SAMARTH Description and Major Businesses
Table 102. SAMARTH Somatostatin Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. SAMARTH Product
Table 104. SAMARTH Recent Development
Table 105. UBPL Corporation Information
Table 106. UBPL Description and Major Businesses
Table 107. UBPL Somatostatin Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. UBPL Product
Table 109. UBPL Recent Development
Table 110. HYBIO Corporation Information
Table 111. HYBIO Description and Major Businesses
Table 112. HYBIO Somatostatin Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 113. HYBIO Product
Table 114. HYBIO Recent Development
Table 115. TianTaiShan Corporation Information
Table 116. TianTaiShan Description and Major Businesses
Table 117. TianTaiShan Somatostatin Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 118. TianTaiShan Product
Table 119. TianTaiShan Recent Development
Table 120. Yangtze River Corporation Information
Table 121. Yangtze River Description and Major Businesses
Table 122. Yangtze River Somatostatin Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. Yangtze River Product
Table 124. Yangtze River Recent Development
Table 125. Siyao Corporation Information
Table 126. Siyao Description and Major Businesses
Table 127. Siyao Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 128. Siyao Product
Table 129. Siyao Recent Development
Table 130. Shuangcheng Corporation Information
Table 131. Shuangcheng Description and Major Businesses
Table 132. Shuangcheng Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 133. Shuangcheng Product
Table 134. Shuangcheng Recent Development
Table 135. Hainan Zhonghe Corporation Information
Table 136. Hainan Zhonghe Description and Major Businesses
Table 137. Hainan Zhonghe Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 138. Hainan Zhonghe Product
Table 139. Hainan Zhonghe Recent Development
Table 140. SL PHARM Corporation Information
Table 141. SL PHARM Description and Major Businesses
Table 142. SL PHARM Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 143. SL PHARM Product
Table 144. SL PHARM Recent Development
Table 145. Wuhan Hualong Corporation Information
Table 146. Wuhan Hualong Description and Major Businesses
Table 147. Wuhan Hualong Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 148. Wuhan Hualong Product
Table 149. Wuhan Hualong Recent Development
Table 150. Qingdao Guoda Corporation Information
Table 151. Qingdao Guoda Description and Major Businesses
Table 152. Qingdao Guoda Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 153. Qingdao Guoda Product
Table 154. Qingdao Guoda Recent Development
Table 155. Chengdu Shengnuo Corporation Information
Table 156. Chengdu Shengnuo Description and Major Businesses
Table 157. Chengdu Shengnuo Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 158. Chengdu Shengnuo Product
Table 159. Chengdu Shengnuo Recent Development
Table 160. Longjin Corporation Information
Table 161. Longjin Description and Major Businesses
Table 162. Longjin Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 163. Longjin Product
Table 164. Longjin Recent Development
Table 165. Global Somatostatin Sales Forecast by Regions (2021-2026) (K Pcs)
Table 166. Global Somatostatin Sales Market Share Forecast by Regions (2021-2026)
Table 167. Global Somatostatin Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 168. Global Somatostatin Revenue Market Share Forecast by Regions (2021-2026)
Table 169. North America: Somatostatin Sales Forecast by Country (2021-2026) (K Pcs)
Table 170. North America: Somatostatin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 171. Europe: Somatostatin Sales Forecast by Country (2021-2026) (K Pcs)
Table 172. Europe: Somatostatin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 173. Asia Pacific: Somatostatin Sales Forecast by Region (2021-2026) (K Pcs)
Table 174. Asia Pacific: Somatostatin Revenue Forecast by Region (2021-2026) (US$ Million)
Table 175. Latin America: Somatostatin Sales Forecast by Country (2021-2026) (K Pcs)
Table 176. Latin America: Somatostatin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 177. Middle East and Africa: Somatostatin Sales Forecast by Country (2021-2026) (K Pcs)
Table 178. Middle East and Africa: Somatostatin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 179. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 180. Key Challenges
Table 181. Market Risks
Table 182. Main Points Interviewed from Key Somatostatin Players
Table 183. Somatostatin Customers List
Table 184. Somatostatin Distributors List
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
Table 1. Somatostatin Market Segments
Table 2. Ranking of Global Top Somatostatin Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Somatostatin Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of 0.25
Table 5. Major Manufacturers of 0.75
Table 6. Major Manufacturers of 3
Table 7. COVID-19 Impact Global Market: (Four Somatostatin Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Somatostatin Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Somatostatin Players to Combat Covid-19 Impact
Table 12. Global Somatostatin Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 13. Global Somatostatin Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 14. Global Somatostatin Sales by Regions 2015-2020 (K Pcs)
Table 15. Global Somatostatin Sales Market Share by Regions (2015-2020)
Table 16. Global Somatostatin Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Somatostatin Sales by Manufacturers (2015-2020) (K Pcs)
Table 18. Global Somatostatin Sales Share by Manufacturers (2015-2020)
Table 19. Global Somatostatin Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Somatostatin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Somatostatin as of 2019)
Table 21. Somatostatin Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Somatostatin Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Somatostatin Price (2015-2020) (USD/Pcs)
Table 24. Somatostatin Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Somatostatin Product Type
Table 26. Date of International Manufacturers Enter into Somatostatin Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Somatostatin Sales by Type (2015-2020) (K Pcs)
Table 29. Global Somatostatin Sales Share by Type (2015-2020)
Table 30. Global Somatostatin Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Somatostatin Revenue Share by Type (2015-2020)
Table 32. Somatostatin Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 33. Global Somatostatin Sales by Application (2015-2020) (K Pcs)
Table 34. Global Somatostatin Sales Share by Application (2015-2020)
Table 35. North America Somatostatin Sales by Country (2015-2020) (K Pcs)
Table 36. North America Somatostatin Sales Market Share by Country (2015-2020)
Table 37. North America Somatostatin Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Somatostatin Revenue Market Share by Country (2015-2020)
Table 39. North America Somatostatin Sales by Type (2015-2020) (K Pcs)
Table 40. North America Somatostatin Sales Market Share by Type (2015-2020)
Table 41. North America Somatostatin Sales by Application (2015-2020) (K Pcs)
Table 42. North America Somatostatin Sales Market Share by Application (2015-2020)
Table 43. Europe Somatostatin Sales by Country (2015-2020) (K Pcs)
Table 44. Europe Somatostatin Sales Market Share by Country (2015-2020)
Table 45. Europe Somatostatin Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Somatostatin Revenue Market Share by Country (2015-2020)
Table 47. Europe Somatostatin Sales by Type (2015-2020) (K Pcs)
Table 48. Europe Somatostatin Sales Market Share by Type (2015-2020)
Table 49. Europe Somatostatin Sales by Application (2015-2020) (K Pcs)
Table 50. Europe Somatostatin Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Somatostatin Sales by Region (2015-2020) (K Pcs)
Table 52. Asia Pacific Somatostatin Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Somatostatin Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Somatostatin Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Somatostatin Sales by Type (2015-2020) (K Pcs)
Table 56. Asia Pacific Somatostatin Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Somatostatin Sales by Application (2015-2020) (K Pcs)
Table 58. Asia Pacific Somatostatin Sales Market Share by Application (2015-2020)
Table 59. Latin America Somatostatin Sales by Country (2015-2020) (K Pcs)
Table 60. Latin America Somatostatin Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Somatostatin Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Somatostatin Revenue Market Share by Country (2015-2020)
Table 63. Latin America Somatostatin Sales by Type (2015-2020) (K Pcs)
Table 64. Latin America Somatostatin Sales Market Share by Type (2015-2020)
Table 65. Latin America Somatostatin Sales by Application (2015-2020) (K Pcs)
Table 66. Latin America Somatostatin Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Somatostatin Sales by Country (2015-2020) (K Pcs)
Table 68. Middle East and Africa Somatostatin Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Somatostatin Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Somatostatin Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Somatostatin Sales by Type (2015-2020) (K Pcs)
Table 72. Middle East and Africa Somatostatin Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Somatostatin Sales by Application (2015-2020) (K Pcs)
Table 74. Middle East and Africa Somatostatin Sales Market Share by Application (2015-2020)
Table 75. Merck (Schweiz) AG Corporation Information
Table 76. Merck (Schweiz) AG Description and Major Businesses
Table 77. Merck (Schweiz) AG Somatostatin Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Merck (Schweiz) AG Product
Table 79. Merck (Schweiz) AG Recent Development
Table 80. SANOFI-AVENTIS FRANCE Corporation Information
Table 81. SANOFI-AVENTIS FRANCE Description and Major Businesses
Table 82. SANOFI-AVENTIS FRANCE Somatostatin Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. SANOFI-AVENTIS FRANCE Product
Table 84. SANOFI-AVENTIS FRANCE Recent Development
Table 85. Lyomark Pharma GmbH Corporation Information
Table 86. Lyomark Pharma GmbH Description and Major Businesses
Table 87. Lyomark Pharma GmbH Somatostatin Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Lyomark Pharma GmbH Product
Table 89. Lyomark Pharma GmbH Recent Development
Table 90. ALFA WASSERMANN S.p.A. Corporation Information
Table 91. ALFA WASSERMANN S.p.A. Description and Major Businesses
Table 92. ALFA WASSERMANN S.p.A. Somatostatin Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. ALFA WASSERMANN S.p.A. Product
Table 94. ALFA WASSERMANN S.p.A. Recent Development
Table 95. Polypeptide Laboratories, Inc Corporation Information
Table 96. Polypeptide Laboratories, Inc Description and Major Businesses
Table 97. Polypeptide Laboratories, Inc Somatostatin Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Polypeptide Laboratories, Inc Product
Table 99. Polypeptide Laboratories, Inc Recent Development
Table 100. SAMARTH Corporation Information
Table 101. SAMARTH Description and Major Businesses
Table 102. SAMARTH Somatostatin Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. SAMARTH Product
Table 104. SAMARTH Recent Development
Table 105. UBPL Corporation Information
Table 106. UBPL Description and Major Businesses
Table 107. UBPL Somatostatin Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. UBPL Product
Table 109. UBPL Recent Development
Table 110. HYBIO Corporation Information
Table 111. HYBIO Description and Major Businesses
Table 112. HYBIO Somatostatin Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 113. HYBIO Product
Table 114. HYBIO Recent Development
Table 115. TianTaiShan Corporation Information
Table 116. TianTaiShan Description and Major Businesses
Table 117. TianTaiShan Somatostatin Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 118. TianTaiShan Product
Table 119. TianTaiShan Recent Development
Table 120. Yangtze River Corporation Information
Table 121. Yangtze River Description and Major Businesses
Table 122. Yangtze River Somatostatin Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. Yangtze River Product
Table 124. Yangtze River Recent Development
Table 125. Siyao Corporation Information
Table 126. Siyao Description and Major Businesses
Table 127. Siyao Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 128. Siyao Product
Table 129. Siyao Recent Development
Table 130. Shuangcheng Corporation Information
Table 131. Shuangcheng Description and Major Businesses
Table 132. Shuangcheng Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 133. Shuangcheng Product
Table 134. Shuangcheng Recent Development
Table 135. Hainan Zhonghe Corporation Information
Table 136. Hainan Zhonghe Description and Major Businesses
Table 137. Hainan Zhonghe Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 138. Hainan Zhonghe Product
Table 139. Hainan Zhonghe Recent Development
Table 140. SL PHARM Corporation Information
Table 141. SL PHARM Description and Major Businesses
Table 142. SL PHARM Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 143. SL PHARM Product
Table 144. SL PHARM Recent Development
Table 145. Wuhan Hualong Corporation Information
Table 146. Wuhan Hualong Description and Major Businesses
Table 147. Wuhan Hualong Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 148. Wuhan Hualong Product
Table 149. Wuhan Hualong Recent Development
Table 150. Qingdao Guoda Corporation Information
Table 151. Qingdao Guoda Description and Major Businesses
Table 152. Qingdao Guoda Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 153. Qingdao Guoda Product
Table 154. Qingdao Guoda Recent Development
Table 155. Chengdu Shengnuo Corporation Information
Table 156. Chengdu Shengnuo Description and Major Businesses
Table 157. Chengdu Shengnuo Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 158. Chengdu Shengnuo Product
Table 159. Chengdu Shengnuo Recent Development
Table 160. Longjin Corporation Information
Table 161. Longjin Description and Major Businesses
Table 162. Longjin Somatostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 163. Longjin Product
Table 164. Longjin Recent Development
Table 165. Global Somatostatin Sales Forecast by Regions (2021-2026) (K Pcs)
Table 166. Global Somatostatin Sales Market Share Forecast by Regions (2021-2026)
Table 167. Global Somatostatin Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 168. Global Somatostatin Revenue Market Share Forecast by Regions (2021-2026)
Table 169. North America: Somatostatin Sales Forecast by Country (2021-2026) (K Pcs)
Table 170. North America: Somatostatin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 171. Europe: Somatostatin Sales Forecast by Country (2021-2026) (K Pcs)
Table 172. Europe: Somatostatin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 173. Asia Pacific: Somatostatin Sales Forecast by Region (2021-2026) (K Pcs)
Table 174. Asia Pacific: Somatostatin Revenue Forecast by Region (2021-2026) (US$ Million)
Table 175. Latin America: Somatostatin Sales Forecast by Country (2021-2026) (K Pcs)
Table 176. Latin America: Somatostatin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 177. Middle East and Africa: Somatostatin Sales Forecast by Country (2021-2026) (K Pcs)
Table 178. Middle East and Africa: Somatostatin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 179. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 180. Key Challenges
Table 181. Market Risks
Table 182. Main Points Interviewed from Key Somatostatin Players
Table 183. Somatostatin Customers List
Table 184. Somatostatin Distributors List
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Somatostatin Product Picture
Figure 2. Global Somatostatin Sales Market Share by Type in 2020 & 2026
Figure 3. 0.25 Product Picture
Figure 4. 0.75 Product Picture
Figure 5. 3 Product Picture
Figure 6. Global Somatostatin Sales Market Share by Application in 2020 & 2026
Figure 7. Hormonal Disorder
Figure 8. Oncology
Figure 9. Metabolic Disorder
Figure 10. Others
Figure 11. Somatostatin Report Years Considered
Figure 12. Global Somatostatin Market Size 2015-2026 (US$ Million)
Figure 13. Global Somatostatin Sales 2015-2026 (K Pcs)
Figure 14. Global Somatostatin Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Somatostatin Sales Market Share by Region (2015-2020)
Figure 16. Global Somatostatin Sales Market Share by Region in 2019
Figure 17. Global Somatostatin Revenue Market Share by Region (2015-2020)
Figure 18. Global Somatostatin Revenue Market Share by Region in 2019
Figure 19. Global Somatostatin Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Somatostatin Revenue in 2019
Figure 21. Somatostatin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Somatostatin Sales Market Share by Type (2015-2020)
Figure 23. Global Somatostatin Sales Market Share by Type in 2019
Figure 24. Global Somatostatin Revenue Market Share by Type (2015-2020)
Figure 25. Global Somatostatin Revenue Market Share by Type in 2019
Figure 26. Global Somatostatin Market Share by Price Range (2015-2020)
Figure 27. Global Somatostatin Sales Market Share by Application (2015-2020)
Figure 28. Global Somatostatin Sales Market Share by Application in 2019
Figure 29. Global Somatostatin Revenue Market Share by Application (2015-2020)
Figure 30. Global Somatostatin Revenue Market Share by Application in 2019
Figure 31. North America Somatostatin Sales Growth Rate 2015-2020 (K Pcs)
Figure 32. North America Somatostatin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Somatostatin Sales Market Share by Country in 2019
Figure 34. North America Somatostatin Revenue Market Share by Country in 2019
Figure 35. U.S. Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 36. U.S. Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. Canada Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Somatostatin Market Share by Type in 2019
Figure 40. North America Somatostatin Market Share by Application in 2019
Figure 41. Europe Somatostatin Sales Growth Rate 2015-2020 (K Pcs)
Figure 42. Europe Somatostatin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Somatostatin Sales Market Share by Country in 2019
Figure 44. Europe Somatostatin Revenue Market Share by Country in 2019
Figure 45. Germany Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. Germany Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. France Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. U.K. Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Italy Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Russia Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Somatostatin Market Share by Type in 2019
Figure 56. Europe Somatostatin Market Share by Application in 2019
Figure 57. Asia Pacific Somatostatin Sales Growth Rate 2015-2020 (K Pcs)
Figure 58. Asia Pacific Somatostatin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Somatostatin Sales Market Share by Region in 2019
Figure 60. Asia Pacific Somatostatin Revenue Market Share by Region in 2019
Figure 61. China Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. China Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. Japan Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. South Korea Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. India Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Australia Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Taiwan Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Indonesia Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Thailand Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Malaysia Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Philippines Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Vietnam Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Somatostatin Market Share by Type in 2019
Figure 84. Asia Pacific Somatostatin Market Share by Application in 2019
Figure 85. Latin America Somatostatin Sales Growth Rate 2015-2020 (K Pcs)
Figure 86. Latin America Somatostatin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Somatostatin Sales Market Share by Country in 2019
Figure 88. Latin America Somatostatin Revenue Market Share by Country in 2019
Figure 89. Mexico Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 90. Mexico Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Brazil Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Argentina Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Somatostatin Market Share by Type in 2019
Figure 96. Latin America Somatostatin Market Share by Application in 2019
Figure 97. Middle East and Africa Somatostatin Sales Growth Rate 2015-2020 (K Pcs)
Figure 98. Middle East and Africa Somatostatin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Somatostatin Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Somatostatin Revenue Market Share by Country in 2019
Figure 101. Turkey Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 102. Turkey Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Saudi Arabia Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. UAE Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. UAE Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Somatostatin Market Share by Type in 2019
Figure 108. Middle East and Africa Somatostatin Market Share by Application in 2019
Figure 109. Merck (Schweiz) AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. SANOFI-AVENTIS FRANCE Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Lyomark Pharma GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. ALFA WASSERMANN S.p.A. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Polypeptide Laboratories, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. SAMARTH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. UBPL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. HYBIO Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. TianTaiShan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Yangtze River Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Siyao Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Shuangcheng Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. Hainan Zhonghe Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. SL PHARM Total Revenue (US$ Million): 2019 Compared with 2018
Figure 123. Wuhan Hualong Total Revenue (US$ Million): 2019 Compared with 2018
Figure 124. Qingdao Guoda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 125. Chengdu Shengnuo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 126. Longjin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 127. North America Somatostatin Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 128. North America Somatostatin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Europe Somatostatin Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 130. Europe Somatostatin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 131. Asia Pacific Somatostatin Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 132. Asia Pacific Somatostatin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 133. Latin America Somatostatin Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 134. Latin America Somatostatin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 135. Middle East and Africa Somatostatin Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 136. Middle East and Africa Somatostatin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 137. Porter's Five Forces Analysis
Figure 138. Channels of Distribution
Figure 139. Distributors Profiles
Figure 140. Bottom-up and Top-down Approaches for This Report
Figure 141. Data Triangulation
Figure 142. Key Executives Interviewed
Figure 1. Somatostatin Product Picture
Figure 2. Global Somatostatin Sales Market Share by Type in 2020 & 2026
Figure 3. 0.25 Product Picture
Figure 4. 0.75 Product Picture
Figure 5. 3 Product Picture
Figure 6. Global Somatostatin Sales Market Share by Application in 2020 & 2026
Figure 7. Hormonal Disorder
Figure 8. Oncology
Figure 9. Metabolic Disorder
Figure 10. Others
Figure 11. Somatostatin Report Years Considered
Figure 12. Global Somatostatin Market Size 2015-2026 (US$ Million)
Figure 13. Global Somatostatin Sales 2015-2026 (K Pcs)
Figure 14. Global Somatostatin Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Somatostatin Sales Market Share by Region (2015-2020)
Figure 16. Global Somatostatin Sales Market Share by Region in 2019
Figure 17. Global Somatostatin Revenue Market Share by Region (2015-2020)
Figure 18. Global Somatostatin Revenue Market Share by Region in 2019
Figure 19. Global Somatostatin Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Somatostatin Revenue in 2019
Figure 21. Somatostatin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Somatostatin Sales Market Share by Type (2015-2020)
Figure 23. Global Somatostatin Sales Market Share by Type in 2019
Figure 24. Global Somatostatin Revenue Market Share by Type (2015-2020)
Figure 25. Global Somatostatin Revenue Market Share by Type in 2019
Figure 26. Global Somatostatin Market Share by Price Range (2015-2020)
Figure 27. Global Somatostatin Sales Market Share by Application (2015-2020)
Figure 28. Global Somatostatin Sales Market Share by Application in 2019
Figure 29. Global Somatostatin Revenue Market Share by Application (2015-2020)
Figure 30. Global Somatostatin Revenue Market Share by Application in 2019
Figure 31. North America Somatostatin Sales Growth Rate 2015-2020 (K Pcs)
Figure 32. North America Somatostatin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Somatostatin Sales Market Share by Country in 2019
Figure 34. North America Somatostatin Revenue Market Share by Country in 2019
Figure 35. U.S. Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 36. U.S. Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. Canada Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Somatostatin Market Share by Type in 2019
Figure 40. North America Somatostatin Market Share by Application in 2019
Figure 41. Europe Somatostatin Sales Growth Rate 2015-2020 (K Pcs)
Figure 42. Europe Somatostatin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Somatostatin Sales Market Share by Country in 2019
Figure 44. Europe Somatostatin Revenue Market Share by Country in 2019
Figure 45. Germany Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. Germany Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. France Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. U.K. Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Italy Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Russia Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Somatostatin Market Share by Type in 2019
Figure 56. Europe Somatostatin Market Share by Application in 2019
Figure 57. Asia Pacific Somatostatin Sales Growth Rate 2015-2020 (K Pcs)
Figure 58. Asia Pacific Somatostatin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Somatostatin Sales Market Share by Region in 2019
Figure 60. Asia Pacific Somatostatin Revenue Market Share by Region in 2019
Figure 61. China Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. China Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. Japan Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. South Korea Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. India Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Australia Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Taiwan Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Indonesia Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Thailand Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Malaysia Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Philippines Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Vietnam Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Somatostatin Market Share by Type in 2019
Figure 84. Asia Pacific Somatostatin Market Share by Application in 2019
Figure 85. Latin America Somatostatin Sales Growth Rate 2015-2020 (K Pcs)
Figure 86. Latin America Somatostatin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Somatostatin Sales Market Share by Country in 2019
Figure 88. Latin America Somatostatin Revenue Market Share by Country in 2019
Figure 89. Mexico Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 90. Mexico Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Brazil Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Argentina Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Somatostatin Market Share by Type in 2019
Figure 96. Latin America Somatostatin Market Share by Application in 2019
Figure 97. Middle East and Africa Somatostatin Sales Growth Rate 2015-2020 (K Pcs)
Figure 98. Middle East and Africa Somatostatin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Somatostatin Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Somatostatin Revenue Market Share by Country in 2019
Figure 101. Turkey Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 102. Turkey Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Saudi Arabia Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. UAE Somatostatin Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. UAE Somatostatin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Somatostatin Market Share by Type in 2019
Figure 108. Middle East and Africa Somatostatin Market Share by Application in 2019
Figure 109. Merck (Schweiz) AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. SANOFI-AVENTIS FRANCE Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Lyomark Pharma GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. ALFA WASSERMANN S.p.A. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Polypeptide Laboratories, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. SAMARTH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. UBPL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. HYBIO Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. TianTaiShan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Yangtze River Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Siyao Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Shuangcheng Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. Hainan Zhonghe Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. SL PHARM Total Revenue (US$ Million): 2019 Compared with 2018
Figure 123. Wuhan Hualong Total Revenue (US$ Million): 2019 Compared with 2018
Figure 124. Qingdao Guoda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 125. Chengdu Shengnuo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 126. Longjin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 127. North America Somatostatin Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 128. North America Somatostatin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Europe Somatostatin Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 130. Europe Somatostatin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 131. Asia Pacific Somatostatin Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 132. Asia Pacific Somatostatin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 133. Latin America Somatostatin Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 134. Latin America Somatostatin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 135. Middle East and Africa Somatostatin Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 136. Middle East and Africa Somatostatin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 137. Porter's Five Forces Analysis
Figure 138. Channels of Distribution
Figure 139. Distributors Profiles
Figure 140. Bottom-up and Top-down Approaches for This Report
Figure 141. Data Triangulation
Figure 142. Key Executives Interviewed
